JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koshimizu, T.-a.
Right arrow Articles by Stojilkovic, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koshimizu, T.-a.
Right arrow Articles by Stojilkovic, S. S.

J Biol Chem, Vol. 274, Issue 53, 37651-37657, December 31, 1999


Contributions of the C-terminal Domain to the Control of P2X Receptor Desensitization*

Taka-aki Koshimizu, Miharu Koshimizu, and Stanko S. StojilkovicDagger

From the Endocrinology and Reproduction Research Branch, NICHD, National Institutes of Health, Bethesda, Maryland 20892

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSSION
REFERENCES

The P2X purinergic receptor channels (P2XRs) differ among themselves with respect to the rates of desensitization during prolonged agonist stimulation. Here we studied the desensitization of recombinant channels by monitoring the changes in intracellular free Ca2+ concentration in cells stimulated with ATP, the native and common agonist for all P2XRs. The focus in our investigations was on the relevance of the P2XR C terminus in controlling receptor desensitization. When expressed in GT1 cells, the P2XRs desensitized with rates characteristic to each receptor subtype: P2X1R = P2X3R > P2X2bR > P2X4R > P2X2aR > P2X7R. A slow desensitizing pattern of P2X2aR was mimicked partially by P2X3R and fully by P2X4R when the six-amino acid sequences of these channels located in the cytoplasmic C terminus were substituted with the corresponding arginine 371 to proline 376 sequence of P2X2aR. Changing the total net charge in the six amino acids of P2X4R to a more positive direction also slowed the receptor desensitization. On the other hand, substitution of arginine 371-proline 376 sequence of P2X2aR with the corresponding sequences of P2X1R, P2X3R, and P2X4R increased the rate of receptor desensitization. Furthermore, heterologous polymerization of wild-type P2X2aR and mutant P2X3R having the C-terminal six amino acids of P2X2aR at its analogous position resulted in a functional channel whose desensitization was significantly delayed. These results suggest that composition of the C-terminal six-amino acid sequence and its electrostatic force influence the rate of receptor desensitization.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSSION
REFERENCES

ATP-gated receptor channels (P2XRs)1 are expressed in a number of tissues where they are involved in regulation of a wide variety of cellular functions, including central and peripheral neurotransmission, smooth muscle contraction, platelet activation, and hormone secretion (1-3). The regulation of these functions by the activated P2XRs requires or is susceptible to local and/or global changes in intracellular Ca2+ concentration ([Ca2+]i) (3). Binding of extracellular ATP to P2XRs is associated with a rise in [Ca2+]i, which is mediated by Ca2+ influx through these channels as well as by depolarization of cells and activation of voltage-gated Ca2+ channels. The pattern of [Ca2+]i signaling by native P2XRs is highly variable, depending on the cell type examined (3). In contrast to other Ca2+-conducting channels, however, the relevant structural base of the P2XRs contributing to the control of [Ca2+]i signaling function has not been completely elucidated.

Using molecular cloning techniques, seven subunits of P2XRs have been obtained so far and are named P2X1R to P2X7R (4-10). They can form Ca2+-permeable pores through homo- and heteropolymerization (11, 12). Each subunit is proposed to have two putative transmembrane helices connected with a large extracellular loop, and both the N and C termini are located in the cytoplasm. From their N termini to the second transmembrane domain, the cloned subunits exhibit a relatively high level of amino acid (aa) sequence homology compared with their C termini, which are variable in lengths and show no apparent sequence homology except for the proximal region near the second transmembrane domain (1). During continuous exposure to agonist, current signals generated by recombinant P2XRs are desensitized gradually, an action that should effectively attenuate or terminate direct and indirect Ca2+ influx.

Based on the observed differences in their current desensitization kinetics, recombinant P2XRs are generally divided into two groups: the rapidly desensitizing (P2X1R and P2X3R) and the slowly desensitizing (P2X2R, P2X4R, P2X5R, P2X6R, and P2X7R) (3). Experiments with chimera subunits composed of P2X2R and P2X1R or P2X3R subunits suggested that the rapid desensitization requires interactions between two transmembrane domains of receptor subunits (13). A large C terminus of P2X7R has also been suggested to account for the nondesensitizing pattern of these channels during repetitive stimulation (10). Recently, a new view of P2XR desensitization has emerged; the C-terminal splice variant of P2X2R, termed P2X2bR or P2X2-2R, was found to lack a stretch of 69 aa and to desensitize faster than the full-length P2X2R, termed P2X2aR (14-16). Amino acids responsible for such a functional difference between the spliced and full-length channels are localized to the initial six residues (Arg371-Pro376) within the spliced segment (17).

Here, we examined the importance of the C-terminal 6-aa sequences of P2XRs, which correspond to Arg371-Pro376 of P2X2aR (Fig. 1), to the desensitization pattern of these channels. For this purpose, P2XRs and their mutants were expressed in GT1 immortalized neurons, and the impact of receptor desensitization on the pattern of [Ca2+]i signaling was analyzed by monitoring single cell [Ca2+]i. These cells are excitable and express two types of voltage-gated calcium channels, T- and L-type (18). On the other hand, neither P2XRs nor Ca2+-mobilizing P2Y receptors are native for these cells (16). Our results indicate that the pattern of receptor desensitization is unique for each homo- and heteropolymeric channel and that the structural differences in the C-terminal small region in part account for such variety of responses.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 1.   Schematic representation of the P2XR with two putative transmembrane domain model and amino acid sequences of the proximal C termini. Shading indicates conserved residues. In the terminal six-amino acid segments shown, negatively charged residues are indicated by squares, and positively charged residues are indicated by circles. The arrow indicates the beginning of the spliced site in P2X2aR C terminus. M1 and M2 indicate the transmembrane domains 1 and 2, and N and C indicate the N and C termini, respectively.


    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSSION
REFERENCES

Expression Constructs and Site-directed Mutagenesis-- Protein coding sequences for rat P2X1R (4), P2X3R (6), P2X4R (19), P2X6R (9), and P2X7R (10) were obtained by PCR with reverse-transcribed mRNA from heart (P2X1R), pituitary (P2X3R), and brain (P2X4R, P2X6R, and P2X7R), respectively. Total RNA was isolated using TrizolTM reagent (Life Technologies, Inc) and was treated with DNase I at 37 °C for 30 min. After heat inactivation of DNase I by incubating it at 70 °C for 15 min, first-strand cDNA was synthesized from 5 µg of total RNA by Superscript II reverse transcriptase and oligo(dT)12-18 primers in a reaction volume of 20 µl. The resulting single-strand cDNA (1 µl) was then used as a template in 25 µl of PCR containing 2 mM each of four deoxynucleoside triphosphates, 50 mM KCl, 10 mM Tris-HCl (pH 8.3), 2 mM MgCl2, and 0.5 units of Ex Taq polymerase (PanVera Corp., Madison WI). Primer annealing sites were selected from 3'- and 5'-untranslated regions and had the following sequences: X1 sense, 5'-GGCCGTGTGGGGTGTTCATCTCT-3'; X1 antisense, 5'-TCCAAAGTCTTGCCTGTCTTCAT-3'; X3 sense, 5'-TAAGTGGCTGTGAGCAGTTTCTC-3'; X3 antisense, 5'-GGAAGCATTGCCTATCTGTTGAA-3'; X4 sense, 5'-TGGCGAGGGGACCCACAGTGTC-3'; X4 antisense, 5'-GAGCCGGGCTCCAACAAGATGT-3'; X6 sense, 5'-ACTGGGACCATGGCTTCTGC-3'; X6 antisense, 5'-AACCACTCCTGAGACACCTG-3'; X7 sense, 5'-CCAGGTCCCGCCGAAACAGAGT-3'; and X7 antisense, 5'-GGCCTAACAATCCCTTCAACAC-3'. In the X6 sense primer, a point mutation (underlined) was introduced to obtain optimum translation efficiency (20). PCR products were separated on a 1% agarose gel, recovered, and subcloned into pBluescript II vector (Stratagene, La Jolla, CA) at its HincII site pretreated with 2'-deoxythymidine and Taq DNA polymerase (Life Technologies, Inc.). Sequences of subcloned inserts were verified in both strands with vector- and insert-specific primers using T7 sequenase (U. S. Biochemical Corp.). Confirmed inserts as well as cDNAs for P2X2aR, P2X2bR, and P2X5R (16) were transferred to pcDNA 3.1 (Invitrogen, Carlsbad, CA) at the XhoI/NotI site for mammalian expression.

All C-terminal mutants were made by a PCR-based overlap extension method (21) using the wild-type receptor cDNA as a template. Entire PCR fragments carrying mutations were subcloned into pBluescript II, sequenced, and transferred to C termini of the wild-type expression constructs using the following restriction sites: ClaI/HindIII, BspEI/HindIII, PstI/HindIII, and SmaI for P2X2aR, P2X3R, P2X4R, and P2X7R mutants, respectively. All restriction enzymes were obtained from New England Biolabs (Beverly, MA). The full-length P2X3R and its chimera mutant with P2X2aR were transferred from pBluescript to a bicistronic enhanced fluorescent protein vector, pIRES2-EGFP (CLONTECH, Palo Alto, CA), at its XhoI/EcoRI site, generating pIRES/P2XR3 and pIRES/P2X3/X2aR, respectively.

Cell Cultures and Transfection-- GT1 cells were cultured in Dulbecco's modified Eagle's medium/Ham's F-12 (1:1) containing 10% (v/v) fetal bovine serum, 100 µg/ml streptomycin, and 100 units/ml penicillin. Procedures for transient transfection in GT1 cells were performed as described (17) with minor modifications. Briefly, cells were plated on coverslips coated with poly-L-lysine at a density of 0.5-1.0 × 105 cell/35-mm dish and allowed to grow for 24 h. On the day of transfection, the total amount of 1.2 µg of expression constructs encoding wild-type or mutant P2XRs was mixed with 8 µl of cationic lipid, LipofectAMINETM, in 1.2 ml of reduced serum medium, Opti-MEM (Life Technologies, Inc.) for 15 min at ambient temperature. The DNA mixture was then applied to cells for 3-5 h and replaced by normal culture medium. The cells were subjected to experiments 24-48 h after the transfection. For co-transfection experiments, a ratio of 1:2 DNA for P2X2aR and pIRES constructs was used, keeping the total DNA amount same as above.

[Ca2+]i Measurements-- For single cell [Ca2+]i measurements, cells were incubated at 37 °C for 60 min with 1 µM fura-2 AM in phenol red- and ATP-free Dulbecco's modified Eagle's medium. The cells were subsequently washed with assay buffer containing 137 mM NaCl, 5 mM KCl, 1.2 mM CaCl2, 1 mM MgCl2, 10 mM HEPES (pH 7.4), and 10 mM glucose and kept for at least 30 min in this medium before measurements. Apyrase (grade I) was purchased from Sigma and used at 20 µg/ml throughout the incubation process indicated. Coverslips with cells were mounted on the stage of an Axiovert 135 microscope (Carl Zeiss, Oberkochen, Germany) attached to the Attofluor digital fluorescence microscopy system (Atto Instruments, Rockville, MD). [Ca2+]i responses were examined under a 40× oil immersion objective during exposure to alternating 340- and 380-nm light beams, and the intensity of light emission at 520 nm was measured. The ratio of light intensities, F340/F380, which reflects changes in [Ca2+]i, was simultaneously followed in several single cells. Cells expressing fluorescence protein were optically detected by an emission signal at 520 nm when excited by 488-nm ultraviolet light and were not detectable by 340- or 380-nm excitations. We thus considered the emission signal from fluorescence protein by 340- or 380-nm excitations within our background level. In co-transfection experiments of P2X2aR cDNA and pIRES vectors, about 75% of fluorescent protein-positive cells responded to 100 µM ATP stimulation and were considered to be co-transfected. Lower co-transfection efficiency below this level tended to show small response, and such experiments were excluded from further analysis.

Calculations-- Since transfection efficiencies and expression levels of recombinant receptors were variable among the cells, only cells showing the peak [Ca2+]i amplitude of more than 1.0 in the F340/F380 ratio scale were further used for evaluating the desensitization rates. The time course of [Ca2+]i response to ATP was fitted to one or two exponential functions using SigmaPlot 5.0 (Jandel Scientific software, San Rafael, CA) with the tolerance value set at 10-5. Significant differences were determined by either Student's t test or one-way analysis variance (ANOVA) followed by Scheffe's test, if applicable; p < 0.05 was considered as significantly different.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSSION
REFERENCES

Desensitization Pattern of Homopolymeric P2XRs-- Our previous results have shown that GT1 cells are a suitable cell model for analyzing the P2X2aR and P2X2bR desensitization by single cell [Ca2+]i measurements (16, 17). Here we show that all members of P2XRs, when expressed individually, responded to 100 µM ATP with a significant rise in [Ca2+]i. In cells transfected with P2X1R or P2X3R cDNA, however, preincubation of cultures with apyrase, an ectonucleotidase that degrades ATP, was necessary to detect any appreciable [Ca2+]i change. Preincubation of P2X2aR-expressing cells with this enzyme did not alter the pattern of [Ca2+]i response compared with that observed in controls (not shown).

The averaged peak [Ca2+]i amplitudes induced by supramaximal concentrations of ATP apparently differed among P2XRs. When stimulated with 100 µM ATP, the amplitudes of [Ca2+]i were comparable among cells expressing P2X2aR, P2X2bR, and P2X4R, whereas 500 µM ATP was required to reach the comparable [Ca2+]i response in P2X7R-transfected cells. The peak [Ca2+]i responses caused by activated P2X1R and P2X3R with 100 µM ATP were about one-third those observed in cultures expressing P2X2aR. A small fraction (less than 10%) of cells transfected with P2X5R or P2X6R cDNAs also responded to 100-500 µM ATP but with the amplitude of [Ca2+]i responses about one-fifth that seen in the P2X2aR. Because of such low and variable [Ca2+]i responses, P2X5R and P2X6R were not employed in further studies.

As illustrated in Fig. 2A, the receptors also differed in their capacities to sustain [Ca2+]i signaling during continuous stimulation with ATP. The P2X1R- and P2X3R-expressing cells completely terminated [Ca2+]i signaling within 1-2 min of stimulation with 100 µM ATP. The [Ca2+]i responses caused by activation of P2X2bR and P2X4R showed a relatively slow decrease compared with those generated by the P2X1R and P2X3R. In contrast, P2X2aR- and P2X7R-expressing cells induced long-lasting [Ca2+]i signals. The P2X2aR-induced [Ca2+]i signals usually decreased to one-third of maximum response, and this steady-state plateau level was reached within 10 min of stimulation. The P2X7R-expressing cells showed no obvious decline in [Ca2+]i response for more than 10 min. In all cases, except for P2X7R, single exponential functions were sufficient to describe the decline rates of [Ca2+]i responses. The mean values of calculated rate constants are shown in Fig. 2B. The rank order of desensitization rates derived from these data (P2X1R = P2X3R > P2X2bR > P2X4R > P2X2aR > P2X7R) was highly comparable with that observed in current measurements (22), confirming the validity of single cell [Ca2+]i measurements as a method for comparative evaluation of receptor desensitization.


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 2.   Pattern of calcium signaling by homopolymeric P2XRs transiently expressed in GT1 cells. A, representative tracings of ATP-induced [Ca2+]i signals, with normalized amplitudes of [Ca2+]i responses (y axes). The P2X7R-expressing cells were stimulated with 500 µM ATP, whereas the other receptor-expressing cells were stimulated with 100 µM ATP. B, the calculated desensitization rates were derived from single exponential fittings. The bars shown are the means ± S.E. derived from the number of trials indicated above the bars. *, p < 0.05 between P2X1R/P2X3R and P2X2bR; **, p < 0.05 between P2X2bR and P2X4R; and ***, p < 0.05 between P2X4R and P2X2aR.

Role of a C-terminal 6-aa Sequence in Receptor Desensitization-- Recently, we found that the Arg371-Pro376 sequence, located in the cytoplasmic region of P2X2aR, is necessary for the slow desensitizing pattern of these receptors (17). As shown in Fig. 1, this 6-aa region is located near the second putative transmembrane domain, and the C-terminal difference in amino acid sequences among the members of P2XRs starts from this region. To study the possible role of structural diversity of this region in the control of receptor desensitization, the Arg371-Pro376 sequence of P2X2aR was introduced to P2X3R and P2X4R instead the native Thr362-Lys367 and Glu376-Gly381 sequences, respectively. Such C-terminal chimeric subunits were termed P2X3/X2aR and P2X4/X2aR (Figs. 1 and 3). Cells expressing the P2X3/X2aR mutant responded to 100 µM ATP with an apparent delay in desensitization of [Ca2+]i signals compared with the wild-type P2X3R (Fig. 3A). Furthermore, the averaged spike [Ca2+]i amplitude was significantly higher in cells expressing P2X3/X2aR than in cells expressing P2X3R (F340/F380: 1.6 ± 0.1 (n = 31) versus 2 ± 0.05 (n = 34), respectively). As seen in wild-type P2X3R, the addition of apyrase to the bath solution was necessary to detect the [Ca2+]i change in P2X3/X2aR-expressing cells, indicating that sensitivity of P2X3R to ATP was not largely affected by introducing Arg371-Pro376 sequence to its C terminus.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 3.   Calcium signaling in GT1 cells expressing chimeric P2XRs bearing the Arg371-Pro376 sequence of P2X2aR. A, pattern of ATP-induced calcium signals in wild-type P2X3R and mutant P2X3/X2aR. Cells were stimulated with 100 µM ATP in the presence of 20 µg/ml apyrase. B, pattern of Ca2+ signaling in cells expressing wild-type P2X4R and mutant P2X4/X2aR. The tracings shown in A and B are computer-derived means from 8-10 single cell recordings. C, comparison of the desensitization rates for native and mutant receptors with or without Arg371-Pro376 sequence. The bars shown are mean ± S.E. derived from the number of trials indicated above the bars. *p < 0.05 or higher among pairs.

Cells expressing P2X4/X2aR also showed a slower desensitization rate compared with the cells transfected with the wild-type P2X4R (Fig. 3B). The calculated time constants for the desensitization rates were 12 ± 2 ms-1 (n = 12) for P2X4R versus 4 ± 0.7 ms-1 (n = 12) for P2X4/X2aR. The averaged peak [Ca2+]i amplitudes induced by 100 µM ATP were elevated in the mutant P2X4/X2aR compared with wild-type P2X4R (F340/F380: 2.1 ± 0.1 (n = 72) and 1.6 ± 0.1 (n = 55), respectively). On the other hand, the half maximal doses of ATP required to induce maximum peak [Ca2+]i response were comparable for wild-type and chimeric channels (0.8 and 1.6 µM, respectively), indicating that ATP is equipotent for both wild-type P2X4R and mutant P2X4/X2aR.

In further studies, the reverse mutation was performed at P2X2aR C terminus by substituting the Arg371-Pro376 sequence for the corresponding 6-aa sequence of P2X3R, P2X4R, and P2X1R, and the mutant P2X2aR subunits were termed P2X2a/X3R, P2X2a/X4R, and P2X2a/X1R, respectively. As shown in Fig. 4, traces b, c, and d, all chimeric subunits formed functional channels in GT1 cells with enhanced desensitization rates when compared with the wild-type P2X2aR (trace a). However, none of the P2X2aR mutants was able to mimic the rate of P2X2bR desensitization (trace e). In terms of averaged peak [Ca2+]i amplitudes, no significant difference in [Ca2+]i responses was observed between wild-type and mutant P2X2aR.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 4.   Calcium signaling in GT1 cells expressing wild-type and mutant P2X2aR. The tracings shown are means from at least 18 recordings. The time constants are shown in Table I.

The relevance of the 6-aa sequence in the control of desensitization in wild-type and chimeric channels are summarized in Fig. 3C and Table I. The rate constant for the desensitization of chimeric P2X4/X2aR was indistinguishable from that of P2X2aR (Fig. 3B). Also, no significant differences were observed between P2X4R and P2X2a/X4R (Table I), indicating that the structural element responsible for the distinct pattern of P2X2aR and P2X4R desensitization is localized to the region of the 6-aa C-terminal sequence. In contrast, the desensitization rates of P2X2a/X1R and P2X2a/X3R were significantly enhanced by mutations but not enough to reproduce responses seen in cells expressing wild-type P2X1R and P2X3R (Table I). Similarly, the desensitization rate of P2X3/X2aR was considerably reduced, but not to the level seen in cells expressing wild-type P2X2aR. Therefore, a part of the subunit molecule other than the C terminus also participates in the control of P2X1R and P2X3R desensitization. This agrees with literature data (13) suggesting that the transmembrane domains are critical for the fast desensitization process of P2X1R and P2X3R signaling.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Desensitization rate of wild-type and mutant P2XR receptors
Data shown are means ± S.E.

We have also analyzed the relevance of P2X7R C-terminal 6-aa sequence on receptor desensitization. The optimized results of the amino acid sequence alignments for P2XRs revealed that Val392-Pro397 sequence of P2X7R corresponds to the Arg371-Pro376 sequence of P2X2aR. However, a 18-aa stretch from Cys362 to Val379 of P2X7R is not related to any other subunit C termini. Thus, an insertion was needed in the alignment (1). Substitution of Val392-Pro397 sequence with the corresponding Glu376-Gly381 sequence of P2X4R generated a functional P2X7/X4R mutant receptor, the Ca2+-signaling function of which was indistinguishable from that of wild-type P2X7R. This suggests that the C-terminal 6-aa sequence of P2X7R subunit is not functionally equivalent to those found in other subunits in terms of controlling receptor desensitization.

Identification of Residues Contributing to the Receptor Desensitization-- The in-frame splicing of the P2X2aR C terminus starts at Val370 (indicated by an arrow in Fig. 1) and effectively removes three positively charged residues from the Arg371-Pro376 sequence. On the other hand, negatively charged residue(s) were found in the corresponding segment of P2X1R, P2X3R, P2X2bR, and P2X4R (Fig. 1), and all these receptors apparently showed faster desensitization than P2X2aR. Such a structural difference raised the possibility that charged residues in this region may play an important role in P2XR desensitization. This is especially relevant for P2X2a/X4R and P2X4/X2aR mutants, whose desensitization patterns were indistinguishable from the wild type P2X4R and P2X2aR, respectively.

To test this, we next evaluated the effects of single amino acid substitution in the P2X4R C terminus on the pattern of ATP-induced [Ca2+]i response. The negatively charged residues in the 6-aa sequence of P2X4R were replaced with neutral ones, or the basic residues of the Arg371-Pro376 sequence were introduced. As shown on Fig. 5, both elimination of negatively charged residues from and introduction of positively charged residue to the position of Glu376 in P2X4R decreased the rate of desensitization. Mutation of Glu379 to a basic lysine residue also resulted in a significant decrease in the rate of desensitization. However, the point mutations at Glu376 or Glu379 could not produce the same extent of desensitization as seen in cells expressing wild-type P2X2aR and mutant P2X4/X2aR. In addition, we constructed two mutant P2X4R subunits having 3-aa substitutions, with native acidic moieties of P2X4R changed to neutral (P2X4E376Q/D377Q/E379Q) or three basic amino acids of P2X2aR introduced at the corresponding sites of P2X4R (P2X4RE376R/E379K/Q380H). Both triple mutants desensitized slower than the wild-type P2X4R (Fig. 5). Thus, changing the amino acid composition and the net charge of this particular C-terminal segment altered the duration of Ca2+ influx induced by P2X4R.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 5.   Desensitization rates of wild-type P2X4R and its mutant receptors expressed in GT1 cells. A, negatively charged residues of wild-type P2X4R (indicated by squares) were substituted with neutral residues (indicated by shading). B, the positively charged residues of P2X2aR (indicated by circles on top bar) were introduced to P2X4R (indicated by shading). The bars shown are mean ± S.E. for at least 20 recordings. The top left bar and dashed lines indicate the rate of wild-type P2X4R desensitization, whereas the top right bar and dotted lines indicate mean values for wild-type P2X2aR desensitization. Asterisks indicate a significant difference compared with P2X4R, p < 0.05 or higher.

Within the Arg371-Pro376 of P2X2aR, Thr372 represents an optimum phosphorylation site, (R/K)XX(T/S), for the type II calcium/calmodulin-dependent protein kinase (23). At the analogous position of Thr372, either glutamate or aspartate was found in P2X1R, P2X3R, P2X2bR, and P2X4R (Fig. 1). We speculated that phosphorylation of the single Thr372 residue or introduction of a negatively charged moiety at this position may change the desensitization rate of P2X2aR. However, substitution of this residue with glutamate or with glutamine did not affect the desensitization rate of mutant channels compared with that of the wild type. The desensitization constants for glutamate- and glutamine-containing mutants were 4 ± 0.3 ms-1 (n = 35) and 5 ± 0.3 ms-1 (n = 21), respectively, and 4 ± 0.2 ms-1 (n = 26) for wild-type channels. Also, no obvious difference was observed in the maximum amplitude of [Ca2+]i response and the EC50 values for ATP between P2X2aR and each C-terminal mutant receptors examined (not shown).

Desensitization Pattern of Heteropolymeric P2XRs-- The co-expression of P2X2aR and P2X3R has been shown to form a heteropolymeric P2XR channel, which exhibits a distinct pharmacological profile and desensitization pattern from those seen in homopolymeric channels (11, 12). We used this particular subunit combination to analyze the impact of the C-terminal structure on the [Ca2+]i-signaling pattern of heteropolymeric channels. GT1 neurons expressing only P2X3R responded to 20 µM AMP-CPP with a rise in [Ca2+]i, the amplitude and desensitization rate of which were highly comparable with that observed in 100 µM ATP-stimulated cells (Fig. 2). When co-expressed, these two subunits generated a channel that also responded to 20 µM AMP-CPP but with the amplitude of response comparable with that observed in homopolymeric P2X2aR stimulated with 100 µM ATP (Fig. 6A). In contrast, cells co-transfected with an empty vector and cDNA for P2X2aR did not respond to this agonist (Fig. 6A).


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 6.   Calcium signaling in GT1 cells expressing heteropolymeric P2XRs. A, pattern of [Ca2+]i signaling in cells co-transfected with P2X2aR + vector, P2X2aR + P2X3R, or P2X2aR + P2X3/X2aR. In chimeric subunit P2X3/X2aR, the Thr362-Lys367 sequence of P2X3R was substituted with Arg371-Pro376 sequence of P2X2aR. The tracings shown are representative from 50-80 records obtained in three independent experiments. ATP was added in cultures already containing AMP-CPP (alpha ,beta -MeATP). B, desensitization rates of heteropolymeric receptors, calculated from experiments with cells stimulated with 20 µM AMP-CPP. Bars shown are means ± S.E., and the asterisk indicates a significant difference (p < 0.05) between means.

Under the continuous presence of AMP-CPP, the subsequent application of 100 µM ATP further increased [Ca2+]i, suggesting the existence of two channels with distinct pharmacological features in a co-transfected cell: AMP-CPP-sensitive and -insensitive (Fig. 6A). When the co-transfected cells were initially stimulated with 100 µM ATP, the subsequent addition of 100 µM AMP-CPP failed to induce any change in [Ca2+]i (not shown). Therefore, all P2XRs-expressed cells were sensitive to ATP and desensitized completely during the initial stimulation. This suggests that the AMP-CPP-mediated rise in [Ca2+]i was initiated by the activation of heteropolymeric P2X2aR + P2X3R, which desensitized more rapidly than the homopolymeric P2X2aR but slowly when compared with P2X3R (Figs. 2 and 6).

The co-expression of the P2X2aR and C-terminal mutant P2X3/X2aR also resulted in the formation of AMP-CPP-sensitive heteropolymeric channels (Fig. 6). However, the desensitization of [Ca2+]i signals generated by these channels was significantly slower than in P2X2aR + P2X3R-expressing cells (9.5 ± 0.3 (n = 63) versus 13.5 ± 0.9 (n = 34), respectively). These results indicate that the C-terminal structure of the participating subunits influences the desensitization of heteropolymeric P2X2aR + P2X3R channels in a manner comparable with that observed in homopolymeric channels. It is also important to stress that the exact subunit stoichometry of the heteropolymeric P2X2aR + P2X3R and P2X2aR + P2X3/X2aR in our experiments is not known and might vary within the cells. To overcome the possible impact of such heterogeneity on conclusions driven from these experiments, the number of recordings from which means were derived was elevated compared with other experiments (see above).

    DISCUSSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSSION
REFERENCES

In this study, we employed GT1 neurons as an expression system to analyze the impact of receptor desensitization on the Ca2+-signaling function of recombinant P2XRs and to identify the role of C terminus in receptor desensitization. The time scale for [Ca2+]i measurements in our experiments was set to be sufficiently long (5-10 min) to incorporate the consequence of a pore dilation effect during ATP stimulation reported by others (24, 25) on Ca2+ signaling. Under such recording conditions, activation of all homopolymeric P2XR by ATP caused a rise in [Ca2+]i, the pattern of which was highly specific for each particular channel. Receptors differed among themselves with respect to the amplitude of Ca2+ response. [Ca2+]i signals initiated by the homopolymeric P2XRs also desensitized with rates characteristic to each receptor subtype: P2X1R = P2X3R > P2X2bR > P2X4R > P2X2aR > P2X7R.

The kinetics of receptor desensitization estimated in single cell [Ca2+]i measurements should be interpreted with two reservations. First, voltage-gated calcium channels, which are expressed by GT1 cells (18), were not silenced during [Ca2+]i recording. Second, although the rank orders for receptor desensitization estimated in current and [Ca2+]i measurements were highly comparable, the time needed to reach the steady desensitized states for P2XRs was significantly longer when estimated in [Ca2+]i measurements (22). This probably reflects the slow kinetics of Ca2+ elimination from the cytoplasm, which was additionally enhanced by the integration of voltage-gated Ca2+ influx during receptor stimulation. Thus, [Ca2+]i recordings are of limited use for studies on the dynamics of channel behavior, and the calculated rates should be interpreted only as a relative indicator of the status of receptor desensitization, especially when compared with results obtained in electrophysiological measurements.

However, we previously found a marked and comparable difference in the desensitization rates of P2X2aR and spliced P2X2bR in both current recordings and single cell [Ca2+]i measurements, the later done under conditions where voltage-gated calcium channels were silent (16). In addition, the amplitudes of [Ca2+]i response induced by these channels were significantly reduced when Ca2+ influx through L-type Ca2+ channels was blocked by nifedipine, but the estimated rate of receptor desensitization was not affected (17). Finally, the rank order of receptor desensitization estimated in [Ca2+]i measurements was highly comparable to those observed by others in current measurements for P2X1R, P2X3R, P2X2aR, P2X2bR, and P2X7R (22).

In our experimental conditions, the rapidly desensitizing P2X1R and P2X3R were unable to induce a measurable increase in [Ca2+]i when GT1 cells were bathed in physiological solution, but the inclusion of apyrase in extracellular space recovered receptors from the desensitized state. This suggests that the spontaneous release or pathological leakage of cellular ATP may prevent the fast-desensitizing receptors from responding to ATP stimulation with an increase in [Ca2+]i. P2X4R exhibited fast desensitization when expressed in oocytes and slow desensitization when expressed in HEK293 cells (19, 26, 27), indicating that experimental conditions, including a difference in amphibian and mammalian expression systems, may change the recombinant channel behavior (24). In our expression system, P2X4R completely desensitized during continuous agonist stimulation. With respect to the rate of desensitization, this channel should be considered as a relatively slow desensitizing one.

These observations support the validity of [Ca2+]i measurements as an indicator of P2X receptor desensitization. Since the pattern of [Ca2+]i response initiated by P2XRs represents signals that encode the activity of these receptors for controlling cellular functions, the time course for desensitization estimated by single cell [Ca2+]i measurements is highly relevant. Also, activation of voltage-gated Ca2+ influx is a physiological mechanism by which P2XRs amplify [Ca2+]i signals in excitable cells in addition to conducting Ca2+ through their pores. All together, these results indicates that selective expression of P2XR subunits in an excitable cell can serve as an effective mechanism for generating specific Ca2+ signals.

Our results further indicate that the variable subunit C termini in part accounts for the observed differences in the desensitization of channels. The structural element controlling the desensitization pattern of P2X2aR and P2X4R appears to be exclusively localized to the 6-aa C-terminal sequence. Within the Arg371-Pro376 of P2X2aR, Thr372 represents an optimum phosphorylation site, (R/K)XX(T/S), for type II calcium/calmodulin-dependent protein kinase and is not present in P2X4R. Nonetheless, this residue is not responsible for the difference in the desensitization of these two channels, as documented in experiments with single amino acid mutations.

It is likely that total net charge in the Arg371-Pro376 sequence of P2X2aR and in the equivalent sequences of P2X3R, and P2X4R is an important determinant of the extent of Ca2+ influx during sustained ATP stimulation. In a case of mutant P2X2aR/X4R, the replacement of three positive net charges with three negative ones in the equivalent segment increased the rate of desensitization compared with P2X2a/X1R or P2X2a/X3R mutant receptors with two and one negative residue, respectively. The relevance of single mutations at the charged residues to P2X4R desensitization was also confirmed. Both removal of negatively charged residues and introduction of positive ones resulted in a significant delay of desensitization. Furthermore, the individual residues in the 6-aa sequence of the P2X4R C terminus were not exactly equivalent in terms of their effects on receptor desensitization. Substitution of amino acids closer to the second transmembrane domain had a more profound impact on the pattern of [Ca2+]i response. This domain is suggested to form a pore-lining region of P2XR (3). Since the 6-aa region of P2XR C termini is located relatively close to the cytoplasmic mouth of the pore, we may speculate that the electrical charge in the 6-aa region has an influence on the overall efficiency of conformational transition to the desensitized state.

In parallel to electrophysiological measurements (11, 12), [Ca2+]i measurements showed that heteropolymerization of P2X2aR and P2X3R results in a channel sensitive to AMP-CPP, which desensitizes with a pattern different from those seen in cells expressing homopolymeric channels. The contribution of each subunit C terminus to [Ca2+]i-signaling profile was additive in this combination of subunits. Furthermore, desensitization of the heteropolymeric channels composed of P2X2aR and P2X3R subunit was delayed by the C-terminal mutation introduced only in the P2X3R subunit. Based on the putative pseudosymmetrical orientation of the channel subunits, heteropolymeric P2X2aR + P2X3R could have the 6-aa C-terminal region of each subunit at an equivalent position around the pore axis. Such a ring-like structure made by the C-terminal-charged residues could determine the pattern of P2XR signaling.

In contrast to the other receptor subunits, mutation at the C-terminal 6-aa sequence of P2X7R did not result in modulation of receptor desensitization. This is not a surprise, since the structure of P2X7R C terminus is distantly related to others. It is the longest C terminus among P2XRs and contains the structural basis underlying the unique feature of this channel, the cell-lytic pore formation. It also shows the least amino acid sequence similarity compared with the other P2XR C termini (10). The amino acid sequence alignment of P2XRs revealed that an 18-aa stretch of P2X7R, with no similarity to others, is positioned proximal to the Val392-Pro397 sequence, which corresponds to the Arg371-Pro376 sequence of P2X2aR (1). This insertion should effectively move the charged 6-aa residues away from the internal mouth of the pore.

A role of the C terminus in receptor signaling is not unique for P2XRs. The contribution of the C terminus to channel gating was reported for other channels, including acetylcholine-gated channels, inward rectifier potassium channels, and mechano-sensitive channels (28-31). In the case of inwardly rectifying potassium channels, which have the same topological architecture as P2XRs, the important determinants of the pore block by Mg2+ and polyamines are mediated by negatively charged residues located in the C terminus and the second transmembrane region (29). The mechanism for P2XR desensitization by the charged C-terminal small segment needs to be further examined by means of structural and biophysical studies.

In conclusion, we show here that the activation of P2XRs by ATP leads to an increase in [Ca2+]i, the pattern of which is highly specific for each channel expressed and determined by the rate of receptor desensitization. The variable C termini of receptor subunits in part account for the observed difference in desensitization rates of homo- and heteropolymeric receptors. The charged residues in the 6-aa C-terminal sequence appear to serve as a common factor influencing the desensitization rates of P2X3R, P2X2aR, P2X2bR, and P2X4R. The structural element responsible for the difference in desensitization rates among P2X2aR, P2X2bR, and P2X4R is exclusively localized to the 6-aa C-terminal sequence. In the case of P2X1R and P2X3R subunits, the structure other than the C termini also participates in the control of desensitization. Finally, P2X7R has a distinct C terminus, as well as a distinct pattern of [Ca2+]i signaling, and further experiments are required to establish the possible relationship between the structure of this terminus and the sustained Ca2+ influx.

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: Section on Cellular Signaling, ERRB/NICHD, Bldg. 49, Rm. 6A-36, 49 Convent Dr., Bethesda, MD 20892-4510. Tel.: 301-496-1638; Fax: 301-594-7031; E-mail: stankos@helix.nih.gov.

    ABBREVIATIONS

The abbreviations used are: P2XR, ATP-gated receptor channels; aa, amino acid(s); PCR, polymerase chain reaction; AMP-CPP, adenosine 5'-(alpha ,beta -methylene)triphosphate.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSSION
REFERENCES

1. Buell, G., Collo, G., and Rassendren, F. (1996) Eur. J. Neurosci. 8, 2221-2228[CrossRef][Medline] [Order article via Infotrieve]
2. North, R. A. (1996) Neurosciences 8, 187-194
3. Ralevic, V., and Burnstock, G. (1998) Pharmacol. Rev. 50, 413-492[Abstract/Free Full Text]
4. Valera, S., Hussy, N., Evans, R. J., Adami, N., North, R. A., Surprenant, A., and Buell, G. (1994) Nature 371, 516-519[CrossRef][Medline] [Order article via Infotrieve]
5. Brake, A. J., Wagenbach, M. J., and Julius, D. (1994) Nature 371, 519-523[CrossRef][Medline] [Order article via Infotrieve]
6. Chen, C.-C., Akoplan, A. N., Sivllott, L., Colquhoun, D., Burnstock, G., and Wood, J. N. (1995) Nature 377, 428-431[CrossRef][Medline] [Order article via Infotrieve]
7. Bo, X., Zhang, Y., Nassar, M., Burnstock, G., and Schoepfer, R. (1995) FEBS Lett. 375, 129-133[CrossRef][Medline] [Order article via Infotrieve]
8. Garcia-Guzman, M., Soto, F., Laube, B., and Stuhmer, W. (1996) FEBS Lett. 338, 123-127
9. Collo, G., North, R. A., Kawashima, E., Merlo-Pich, E., Neidhart, S., Surprenant, A., and Buell, G. (1996) J. Neurosci. 16, 2495-2507[Abstract/Free Full Text]
10. Surprenant, A., Rassendren, F., Kawashima, E., North, R. A., and Buell, G. (1996) Science 272, 735-738[Abstract]
11. Lewis, C., Neidhart, S., Holy, C., North, R. A., Buell, G., and Surprenant, A. (1995) Nature 377, 432-435[CrossRef][Medline] [Order article via Infotrieve]
12. Radford, K. M., Virginio, C., Surprenant, A., North, A., and Kawashima, E. (1997) J. Neurosci. 17, 6529-6533[Abstract/Free Full Text]
13. Werner, P., Seward, E. P., Buell, G. N., and North, R. A. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 15485-15490[Abstract/Free Full Text]
14. Brandle, U., Spielmanns, P., Osteroth, R., Sim, J., Surprenant, A., Buell, G., Ruppersberg, J. P., Plinkert, P. K., Zenner, H. P., and Glowatzki, E. (1997) FEBS Lett. 404, 294-298[CrossRef][Medline] [Order article via Infotrieve]
15. Simon, J., Kidd, E. J., Smith, F. M., Chessell, I. P., Murrell-Lagnado, R., Humphrey, P. P. A., and Barnard, E. A. (1997) Mol. Pharmacol. 52, 237-248[Abstract/Free Full Text]
16. Koshimizu, T., Tomic, M., Van Goor, F., and Stojilkovic, S. S. (1998) Mol. Endocrinol. 12, 901-913[Abstract/Free Full Text]
17. Koshimizu, T., Tomic, M., Koshimizu, M., and Stojilkovic, S. S. (1998) J. Biol. Chem. 273, 12853-12857[Abstract/Free Full Text]
18. Van Goor, F., Krsmanovic, L. Z., Catt, K. J., and Stojilkovic, S. S. (1999) Mol. Endocrinol. 13, 587-603[Abstract/Free Full Text]
19. Buell, G., Lewis, C., Collo, G., North, R. A., and Surprenant, A. (1996) EMBO J. 15, 55-62[Medline] [Order article via Infotrieve]
20. Kozak, M. (1991) J. Cell Biol. 115, 887-903[Abstract/Free Full Text]
21. Horton, R. M., Hunt, H. D., Ho, S. N., Pullen, J. K., and Pease, L. R. (1989) Gene 77, 61-68[CrossRef][Medline] [Order article via Infotrieve]
22. Evans, R. J., Surprenant, A., and North, R. A. (1997) in The P2 Nucleotide Receptors (Turner, J. T. , Weisman, G. A. , and Fedan, J. S., eds) , pp. 43-61, Humana Press Inc., Totowa, NJ
23. Pearson, R. B., and Kemp, B. E. (1991) Methods Enzymol. 200, 62-81[Medline] [Order article via Infotrieve]
24. Khakh, B. S., Bao, X. R., Labarca, C. & Lester, H. A. (1999) 2, 322-330
25. Virginio, C., MacKenzie, A., Rassendren, F. A., North, R. A., and Surprenant. (1999) Nat. Neurosci. 2, 315-321[CrossRef][Medline] [Order article via Infotrieve]
26. Soto, F., Garcia-Guzman, M., Gomez-Hernandez, J. M., Hollmann, M., Karschin, C., and Stuhmer, W. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 3684-3688[Abstract/Free Full Text]
27. Seguela, P., Haghighi, A., Soghomonian, J., and Cooper, E. (1996) J. Neurosci. 16, 448-455[Abstract/Free Full Text]
28. Yang, J., Jan, Y. N., and Jan, L. Y. (1995) Neuron 15, 1047-1054
29. Pessia, M., Bond, C. T., Kavanaugh, M. P., and Adelman, J. P. (1995) Neuron 14, 1039-1045[CrossRef][Medline] [Order article via Infotrieve]
30. Corringer, P. J., Bertrand, S., Galzi, J. L., Devillers-Thiery, A., Changeux, J. P., and Bertrand, D. (1999) Neuron 22, 831-843[CrossRef][Medline] [Order article via Infotrieve]
31. Chang, G., Spencer, R. H., Lee, A. T., Barclay, M. T., and Rees, D. C. (1998) Science 282, 2220-2226[Abstract/Free Full Text]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. del Rey, V. Renigunta, A. H. Dalpke, J. Leipziger, J. E. Matos, B. Robaye, M. Zuzarte, A. Kavelaars, and P. J. Hanley
Knock-out Mice Reveal the Contributions of P2Y and P2X Receptors to Nucleotide-induced Ca2+ Signaling in Macrophages
J. Biol. Chem., November 17, 2006; 281(46): 35147 - 35155.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
Y. Fujiwara and Y. Kubo
Regulation of the desensitization and ion selectivity of ATP-gated P2X2 channels by phosphoinositides
J. Physiol., October 1, 2006; 576(1): 135 - 149.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. Fabbretti, M. D'Arco, A. Fabbro, M. Simonetti, A. Nistri, and R. Giniatullin
Delayed upregulation of ATP P2X3 receptors of trigeminal sensory neurons by calcitonin gene-related peptide.
J. Neurosci., June 7, 2006; 26(23): 6163 - 6171.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. J. Fountain and R. A. North
A C-terminal Lysine That Controls Human P2X4 Receptor Desensitization
J. Biol. Chem., June 2, 2006; 281(22): 15044 - 15049.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T.-a. Koshimizu, K. Kretschmannova, M.-L. He, S. Ueno, A. Tanoue, N. Yanagihara, S. S. Stojilkovic, and G. Tsujimoto
Carboxyl-Terminal Splicing Enhances Physical Interactions between the Cytoplasmic Tails of Purinergic P2X Receptors
Mol. Pharmacol., May 1, 2006; 69(5): 1588 - 1598.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Masin, D. Kerschensteiner, K. Dumke, M. E. Rubio, and F. Soto
Fe65 Interacts with P2X2 Subunits at Excitatory Synapses and Modulates Receptor Function
J. Biol. Chem., February 17, 2006; 281(7): 4100 - 4108.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
S. S. STOJILKOVIC, M. TOMIC, M.-L. HE, Z. YAN, T.-A. KOSHIMIZU, and H. ZEMKOVA
Molecular Dissection of Purinergic P2X Receptor Channels
Ann. N.Y. Acad. Sci., June 1, 2005; 1048(1): 116 - 130.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Z. Yan, Z. Liang, M. Tomic, T. Obsil, and S. S. Stojilkovic
Molecular Determinants of the Agonist Binding Domain of a P2X Receptor Channel
Mol. Pharmacol., April 1, 2005; 67(4): 1078 - 1088.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Fabbretti, E. Sokolova, L. Masten, M. D'Arco, A. Fabbro, A. Nistri, and R. Giniatullin
Identification of Negative Residues in the P2X3 ATP Receptor Ectodomain as Structural Determinants for Desensitization and the Ca2+-sensing Modulatory Sites
J. Biol. Chem., December 17, 2004; 279(51): 53109 - 53115.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H. Zemkova, M.-L. He, T.-a. Koshimizu, and S. S. Stojilkovic
Identification of Ectodomain Regions Contributing to Gating, Deactivation, and Resensitization of Purinergic P2X Receptors
J. Neurosci., August 4, 2004; 24(31): 6968 - 6978.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Chaumont, L.-H. Jiang, A. Penna, R. A. North, and F. Rassendren
Identification of a Trafficking Motif Involved in the Stabilization and Polarization of P2X Receptors
J. Biol. Chem., July 9, 2004; 279(28): 29628 - 29638.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Rettinger and G. Schmalzing
Desensitization Masks Nanomolar Potency of ATP for the P2X1 Receptor
J. Biol. Chem., February 20, 2004; 279(8): 6426 - 6433.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M.-L. He, H. Zemkova, T.-a. Koshimizu, M. Tomic, and S. S. Stojilkovic
Intracellular calcium measurements as a method in studies on activity of purinergic P2X receptor channels
Am J Physiol Cell Physiol, August 1, 2003; 285(2): C467 - C479.
[Abstract] [Full Text] [PDF]